Related Experiment Video
Updated: Jan 10, 2026

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
Published on: May 13, 2022
[Recent progress in research on oxidative stress in glaucoma].
Xibin Zhou1, Rui Liu1, Zhihong Wu1
1Department of Ophthalmology , General Hospital of Chinese People's Armed Police Forces, Beijing 100039, China.
Glaucoma causes retinal cell death and axon loss, potentially driven by oxidative stress. Antioxidant therapies show promise in managing this condition.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Glaucoma is characterized by retinal ganglion cell apoptosis and axonal degeneration.
- The exact pathogenesis of glaucoma remains incompletely understood.
- Oxidative stress is increasingly implicated in glaucoma's development and progression.
Purpose of the Study:
- To review the role of oxidative stress in glaucoma pathogenesis.
- To discuss the potential of antioxidant therapies for glaucoma.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of oxidative stress markers in glaucoma patients.
- Evaluation of antioxidant treatment efficacy.
Main Results:
- Oxidative stress markers are present in glaucoma patients' serum and ocular tissues.
- Antioxidant interventions have demonstrated a role in controlling glaucoma progression.
Conclusions:
- Oxidative stress is a significant factor in glaucoma pathogenesis.
- Targeting oxidative stress with antioxidant therapy presents a viable therapeutic strategy for glaucoma.
More Related Videos
10:00Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
12:59Assessment of Oxidative Damage in the Primary Mouse Ocular Surface Cells/Stem Cells in Response to Ultraviolet-C UV-C Damage
Published on: February 15, 2020
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...